Skip to main content
Clinical Trials/NCT06708728
NCT06708728
Not yet recruiting
Not Applicable

Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease

Sohag University1 site in 1 country60 target enrollmentDecember 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemolytic Anemia
Sponsor
Sohag University
Enrollment
60
Locations
1
Primary Endpoint
intensive care unit admission of the patients due to progression of the disease complications.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.

And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Registry
clinicaltrials.gov
Start Date
December 2024
End Date
June 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Elsayed Mahmoud

resident doctor

Sohag University

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 years and older.
  • Patients diagnosed with acquired hemolytic anemia.
  • Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
  • Patients (or their legal representatives) must provide informed

Exclusion Criteria

  • Patients with underlying neoplastic diseases.
  • Patients with hereditary hemolytic anemia.
  • Patients or their representatives who do not consent to participate in the study.

Outcomes

Primary Outcomes

intensive care unit admission of the patients due to progression of the disease complications.

Time Frame: through study completion, an average of 6 months

Primary outcome will be ICU admission due to progression of the disease complications.

Secondary Outcomes

  • mortality within duration of hospital admission(through study completion, an average of 6 months)

Study Sites (1)

Loading locations...

Similar Trials